Table 4 CD34 /VEGF3/AXNA5/CRKI/II/RAC1 expression decreased in tumors from Hca-P-ANXA5-shRNA1 bearing mice

From: Annexin A5 regulates hepatocarcinoma malignancy via CRKI/II-DOCK180-RAC1 integrin and MEK-ERK pathways

Molecule

Group

The 10th Day

P

The 21st Day

P

+

++

+++

+

++

+++

CD34

Hca-P-Anxa5-shControl

2

2

1

1

0.072

0

1

5

6

0.002

Hca-P-Anxa5-shRNA1

5

1

0

0

8

2

2

0

VEGF3

Hca-P-Anxa5-shControl

1

3

2

0

0.21

1

0

4

7

0.002

Hca-P-Anxa5-shRNA1

4

1

1

0

7

3

2

0

ANXA5

Hca-P-Anxa5-shControl

0

1

2

3

0.004

0

2

5

5

0.001

Hca-P-Anxa5-shRNA1

4

2

0

0

9

3

0

0

CRKI/II

Hca-P-Anxa5-shControl

2

0

1

3

0.309

1

1

4

6

0.041

Hca-P-Anxa5-shRNA1

3

1

1

1

5

3

1

3

RAC1

Hca-P-Anxa5-shControl

0

2

2

2

0.238

0

1

5

6

0.013

Hca-P-Anxa5-shRNA1

1

3

1

1

1

7

2

2